News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Treating Epilepsy: Key Takeaways From AES 2020

EP. 1: Phase 4 ELEVATE Study

ByTrevor J. Resnick, MD,Amit Verma, MD

January 13th 2021

EP. 2: Clinical Benefit of Fenfluramine in Dravet Syndrome

ByTrevor J. Resnick, MD,Amit Verma, MD

January 14th 2021

EP. 3: Safety and Efficacy of CBD in Patients With TSC

ByTrevor J. Resnick, MD,Amit Verma, MD

January 17th 2021

EP. 4: ELEKTRA Study in Dravet and Lennox-Gastaut Syndromes

ByTrevor J. Resnick, MD,Amit Verma, MD

January 19th 2021

EP. 5: Focal Seizures: Post-hoc Analysis of Cenobamate

ByTrevor J. Resnick, MD,Amit Verma, MD

January 20th 2021

EP. 6: FAME Study: Partial-Onset Seizures

ByTrevor J. Resnick, MD,Amit Verma, MD

February 4th 2021

EP. 7: BELIEVE Trial: Developmental and Epileptic Encephalopathies

ByTrevor J. Resnick, MD,Amit Verma, MD

February 8th 2021

EP. 8: Interim Analysis of Diazepam Nasal Spray in Epilepsy

ByTrevor J. Resnick, MD,Amit Verma, MD

February 9th 2021

EP. 9: Using Midazolam Nasal Spray for Seizure Clusters

ByTrevor J. Resnick, MD,Amit Verma, MD

February 15th 2021

EP. 10: QoL of Cenobamate in Treatment-Resistant Epilepsy

ByTrevor J. Resnick, MD,Amit Verma, MD

February 17th 2021

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

NeurologyLive® Friday 5 — November 7, 2025

Neflamapimod Phase 3 Trial in DLB, Troriluzole Gets CRL for SCA, Periodontal Disease and Stroke Risk

Survey Study Highlights Interest, Motivations Behind Modifier Gene Testing for Huntington Disease

Supplemental New Drug Application Submitted for AXS-05 as Treatment for Alzheimer Disease Agitation

ALS Qualitative Study Highlights Complexities of Decision-Making Process for Medical Aid in Dying (MAID)

© 2025 MJH Life Sciences^®

All rights reserved.